# Li Wang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/li-wang-3/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,375 |
| Field | Liver Diseases and Immunity |
| h-index | 36 |
| i10-index | 107 |
| Last Known Institution | Guiyang Medical University |
| OpenAlex ID | https://openalex.org/A5100336169 |
| ORCID iD | 0000-0003-0899-5703 |
| Works | 259 |

## Researcher papers

- [The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment](https://scholariq.org/papers/the-oral-and-gut-microbiomes-are-perturbed-in-rheumatoid-arthritis-and-partly/)
- [Clinical characteristics of immunoglobulin G4–related disease: a prospective study of 118 Chinese patients](https://scholariq.org/papers/clinical-characteristics-of-immunoglobulin-g4-related-disease-a-prospective/)
- [A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23](https://scholariq.org/papers/a-genome-wide-association-study-in-han-chinese-identifies-a-susceptibility-locus/)
- [Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis](https://scholariq.org/papers/metagenomic-profiling-of-the-pro-inflammatory-gut-microbiota-in-ankylosing/)
- [Complement C1q synergizes with PTX3 in promoting NLRP3 inflammasome over-activation and pyroptosis in rheumatoid arthritis](https://scholariq.org/papers/complement-c1q-synergizes-with-ptx3-in-promoting-nlrp3-inflammasome-over/)
- [Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study](https://scholariq.org/papers/early-biochemical-response-to-ursodeoxycholic-acid-and-long-term-prognosis-of/)
- [Investigation of bacterial microorganisms in the conjunctival sac of clinically normal dogs and dogs with ulcerative keratitis in Beijing, China](https://scholariq.org/papers/investigation-of-bacterial-microorganisms-in-the-conjunctival-sac-of-clinically/)
- [Risk factors for progression and prognosis of rheumatoid arthritis–associated interstitial lung disease: single center study with a large sample of Chinese population](https://scholariq.org/papers/risk-factors-for-progression-and-prognosis-of-rheumatoid-arthritis-associated/)
- [Animal and Organoid Models of Liver Fibrosis](https://scholariq.org/papers/animal-and-organoid-models-of-liver-fibrosis/)
- [Identification of New Autoantigens for Primary Biliary Cirrhosis Using Human Proteome Microarrays](https://scholariq.org/papers/identification-of-new-autoantigens-for-primary-biliary-cirrhosis-using-human/)
- [Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells](https://scholariq.org/papers/artesunate-may-inhibit-liver-fibrosis-via-the-fak-akt-catenin-pathway-in-lx-2/)

## Researcher topics

- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Researcher university

- [Guiyang Medical University](https://scholariq.org/institutions/guiyang-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.